Orinda, CA, United States of America

Richard S Stephens

This inventor holds 9 USPTO granted patents. Top assignee: University of California. Active years: 2004-2014.


% Patents Active = 11.1

Average Co-Inventor Count = 2.1

ph-index = 4

Forward Citations = 80(Granted Patents)


Company Filing History:


Years Active: 2004-2014

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Richard S. Stephens

Introduction

Richard S. Stephens is a notable inventor based in Orinda, California. He has made significant contributions to the field of biotechnology, particularly in the development of peptides related to the PorB polypeptide. With a total of 9 patents to his name, his work has implications for therapeutic agents and immune response induction.

Latest Patents

Among his latest patents, Richard has developed peptides of a PorB polypeptide that are useful in the production of antibodies. These antibodies bind to the full-length PorB polypeptide and serve as therapeutic agents. His inventions include compositions comprising one or more PorB peptides, which contain at least one epitope capable of eliciting neutralizing antibodies. Additionally, he has devised methods for inducing a protective immune response against infections.

Career Highlights

Richard S. Stephens is affiliated with the University of California, where he continues to advance research in his field. His innovative work has garnered attention and respect within the scientific community, contributing to advancements in medical therapies.

Collaborations

Richard has collaborated with notable colleagues, including Diane Kawa and Aya Kubo. These partnerships have further enriched his research and development efforts.

Conclusion

Richard S. Stephens exemplifies the spirit of innovation in biotechnology through his impactful patents and collaborations. His work continues to pave the way for advancements in therapeutic applications and immune response strategies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…